Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03898596 · ClinicalTrials.gov registry record · NA
Umbilical Vessel Catheterization Under ECG Monitoring and Guidance
A NA study of Pediatric ALL, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT03898596: Recruiting NA study of Pediatric ALL, sponsored by Stanford University.
NCT03898596 is a NA study of Pediatric ALL that is actively recruiting participants, run by Stanford University. The registered enrollment target is 150 participants, below the 1,641-participant average among 21 other Pediatric ALL trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03898596, a NA study of Pediatric ALL, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Umbilical venous catheters (UVC) are typically places with poor guidance and some radiological confirmation. Misplacement of the catheter could lead to its placement in other unintended anatomical areas such as the liver or the spleen, which could be detrimental in critically-ill infants. Our study aims at using a more non-invasive means of placing and continuously monitoring catheter placement using superficial electrocardiogram (ECG) tracings.
Primary Outcome
A normal heart rhythm contains a P wave, a QRS, and a T wave. Readings will include amplitude, deflection, and duration of such elements to record electrical heart activity.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST ECG
Study Locations (1)
California
- Lucille Packard Children's Hospital - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2020-08-25 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT03898596 shows while recruiting
NCT03898596 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,641-participant average among 21 other Pediatric ALL trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Pediatric ALL appearing as the primary indexed condition, and to 1 intervention - of which ECG is the first listed.
NCT03898596 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03898596 about?
NCT03898596 is a clinical study titled "Umbilical Vessel Catheterization Under ECG Monitoring and Guidance". Umbilical venous catheters (UVC) are typically places with poor guidance and some radiological confirmation. Misplacement of the catheter could lead to its placement in other unintended anatomical areas such as the liver or the spleen, which could be detrimental in critically-ill infants. Our study ...
What is the current status of trial NCT03898596?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2020-08-25. Estimated completion is 2025-12.
What conditions does trial NCT03898596 study?
This clinical trial studies the following conditions: Pediatric ALL.
What interventions are being tested in trial NCT03898596?
The interventions under investigation include: ECG (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03898596?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03898596 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric ALL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03898596's enrollment target sits among peer trials
150 8th of 21 higher than 14 of 21 other Pediatric ALL trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric ALL trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
-
PRotein Optimization With eXercise to Improve MUscle Mass and Functional outcomeS
RECRUITING · NA
-
Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
RECRUITING · NA
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
HEalth Advocate for Liver Transplant - Pilot
RECRUITING · NA
-
Multicenter HomeVENT: Home Values and Experiences Navigation Track
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI